Centre approves increase in production of Remdesivir and reducing its prices


Deprecated: strlen(): Passing null to parameter #1 ($string) of type string is deprecated in /home/medicircle/public_html/script_newsdetails.php on line 75
▴
ED has been directed to act against black marketing of Remdesivir

The government has decided to increase the production and supply of Remdesivir and also to reduce its prices in the country. It has approved seven additional sites having a production capacity of 10 Lakh vials per month to six manufacturers.

The current total installed capacity of the seven manufacturers of Remdesivir in the country is 38 lakh 80 thousand vials per month. Minister of State for Chemicals and Fertilizers Mansukh Mandaviya today reviewed the issue of availability of Remdesivir in the country.

The Ministry said, another 30 lakh vials per month production is lined up. This will ramp up the production capacity for manufacturing to around 78 lakh vials per month. Earlier the government had prohibited exports of injection Remdesivir to increase the supply in the Domestic Market.


The Ministry said, manufacturers of Remdesivir have volunteered to reduce the price to less than 3,500 by the end of this week, to support the efforts to Fight against COVID. The manufactures have been directed to give priority to fulfil hospital and institutional level supplies.

Enforcement Authorities of States and Central Government have also been directed by Drugs Controller General of India, DCGI to take immediate action on the incidence of black-marketing, hoarding and overcharging of Remdesivir. The Ministry said National Pharmaceutical Pricing Authority is continuously monitoring the availability of Remdesivir.

Tags : #CentralGovernment #Remdesivir #DCGI #ED #EnforcementDiectorate #RemdesivirBlackMarketing

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

Digital Identity Fraud in Healthcare: What India Must KnowNovember 18, 2026
Wearables in Clinical Care: When Should Doctors Trust the Data?November 18, 2026
Cybersecurity for Medical Startups: What Founders MissNovember 18, 2026
Remote Patient Monitoring: The Next Phase of Virtual CareNovember 18, 2026
Digital Health Wallets: Future of Medical Records in IndiaNovember 17, 2026
How Hospitals Can Prepare for a Transparent Healthcare MarketNovember 17, 2026
Childhood Nutrition: Understanding Micronutrient Gaps Beyond CaloriesNovember 16, 2026
Anaemia in Adolescent Girls: Connecting Prevention, Testing and Nutrition SupportNovember 16, 2026
Health Information Exchanges in India: Are Medical Records Finally Going Portable?November 16, 2026
Hospital Accreditation in 2026: What Is Changing Beyond the Checklist?November 16, 2026
Digital Insurance Platforms and India's Health Coverage FutureNovember 14, 2026
ABDM 2.0: India's Digital Health Ecosystem FutureNovember 14, 2026
Vaccine Cold-Chain Management: Protecting Immunisation Quality From Storage to DeliveryNovember 14, 2026
Foodborne Illness Surveillance: How Public Health Systems Track RisksNovember 14, 2026
Interoperability in Indian Healthcare: Why Patient Data Still StrugglesNovember 13, 2026
Tuberculosis Contact Screening: How Preventive Care Works Around ExposureNovember 13, 2026
COPD Care in India: Linking Diagnosis, Inhaler Education and Follow-UpNovember 13, 2026
Management of ANCA Glomerulonephritis: Induction & Maintenance ProtocolsNovember 12, 2026
Smart Hospital Command Centres Transforming IndiaNovember 12, 2026
Gamma Knife Surgery in India: What You Need to KnowNovember 12, 2026